Bellevue Life Sciences Acquisition Corp

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bellevue Life Sciences Acquisition Corp. is a blank check company. Its objectives are to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.

BELLEVUE, Wash. , Feb. 21, 2023 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (the "Company" or "we") today announced the closing of the over-allotment option that the Company granted to the underwriters of its initial public offering.

Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment Option

News for Bellevue Life Sciences Acquisition Corp Stock (BLACU)